|
EIF2AK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.179300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.197000E-03 |
| Normal-vs-Stage2 |
2.561700E-03 |
| Normal-vs-Stage3 |
5.160900E-03 |
| Normal-vs-Stage4 |
1.600260E-02 |
| Stage1-vs-Stage2 |
4.316800E-01 |
| Stage1-vs-Stage3 |
7.714800E-01 |
| Stage1-vs-Stage4 |
7.927800E-01 |
| Stage2-vs-Stage3 |
5.963600E-01 |
| Stage2-vs-Stage4 |
6.794600E-01 |
| Stage3-vs-Stage4 |
9.671600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.603100E-03 |
| Normal-vs-AfricanAmerican |
7.515800E-01 |
| Normal-vs-Asian |
4.279500E-03 |
| Caucasian-vs-AfricanAmerican |
1.375150E-01 |
| Caucasian-vs-Asian |
4.374000E-01 |
| AfricanAmerican-vs-Asian |
8.860400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.840130E-04 |
| Normal-vs-Female |
7.777600E-03 |
| Male-vs-Female |
1.383380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.597900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.821600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.843170E-03 |
| Normal-vs-Age(81-100Yrs) |
2.929700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.827700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.238000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.653800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.650200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.715600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.683800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.448000E-01 |
| Classical-VS-Follicular |
3.242000E-04 |
| Classical-VS-Other |
8.175700E-04 |
| Classical-VS-Normal |
3.592000E-02 |
| Tall-VS-Follicular |
6.114200E-02 |
| Tall-VS-Other |
1.328010E-02 |
| Tall-VS-Normal |
8.246100E-02 |
| Follicular-VS-Other |
1.703410E-01 |
| Follicular-VS-Normal |
1.83170000001009E-06 |
| Other-VS-Normal |
1.74624000000012E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.775300E-04 |
| Normal-vs-N1 |
5.748200E-02 |
| N0-vs-N1 |
4.608400E-01 |
|
|
